Nordea Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$122M Buy
2,033,068
+1,832,750
+915% +$107M 0.11% 175
2025
Q4
$10.8M Sell
200,318
-319,832
-61% -$15.4M 0.01% 432
2025
Q3
$23.2M Buy
520,150
+17,464
+3% +$816K 0.02% 330
2025
Q2
$23.4M Sell
502,686
-122,454
-20% -$6.01M 0.02% 319
2025
Q1
$38.4M Sell
625,140
-4,880,722
-89% -$284M 0.04% 285
2024
Q4
$311M Sell
5,505,862
-815,575
-13% -$45.6M 0.33% 80
2024
Q3
$325M Buy
6,321,437
+548,854
+10% +$25.7M 0.37% 72
2024
Q2
$243M Sell
5,772,583
-1,919,815
-25% -$85.9M 0.29% 97
2024
Q1
$416M Sell
7,692,398
-3,429,993
-31% -$175M 0.49% 51
2023
Q4
$570M Sell
11,122,391
-554,040
-5% -$29.1M 0.72% 26
2023
Q3
$681M Sell
11,676,431
-384,399
-3% -$23.6M 0.95% 21
2023
Q2
$774M Sell
12,060,830
-13,671
-0.1% -$917K 1.06% 16
2023
Q1
$834M Buy
12,074,501
+863,174
+8% +$60.9M 1.22% 13
2022
Q4
$803M Sell
11,211,327
-506,199
-4% -$38.2M 1.25% 13
2022
Q3
$840M Sell
11,717,526
-1,342,061
-10% -$97.4M 1.36% 11
2022
Q2
$1B Sell
13,059,587
-2,342,256
-15% -$178M 1.49% 7
2022
Q1
$1.13B Sell
15,401,843
-2,728,612
-15% -$183M 1.42% 7
2021
Q4
$1.14B Buy
18,130,455
+3,124,811
+21% +$183M 1.36% 8
2021
Q3
$907M Buy
15,005,644
+1,168
+0% +$76.9K 1.18% 14
2021
Q2
$1B Buy
15,004,476
+1,441,460
+11% +$94M 1.34% 12
2021
Q1
$854M Buy
13,563,016
+332,418
+3% +$20.7M 1.24% 16
2020
Q4
$821M Sell
13,230,598
-11,822
-0.1% -$727K 1.32% 12
2020
Q3
$793M Sell
13,242,420
-6,379,918
-33% -$384M 1.49% 12
2020
Q2
$1.13B Buy
19,622,338
+9,660,989
+97% +$578M 1.17% 22
2020
Q1
$551M Buy
9,961,349
+145,849
+1% +$8.91M 1.33% 17
2019
Q4
$625M Sell
9,815,500
-1,949,835
-17% -$112M 1.25% 17
2019
Q3
$604M Buy
11,765,335
+4,080,024
+53% +$192M 1.32% 15
2019
Q2
$349M Buy
7,685,311
+1,432,464
+23% +$66.7M 0.78% 33
2019
Q1
$298M Buy
6,252,847
+4,950,748
+380% +$247M 0.62% 46
2018
Q4
$67.7M Buy
1,302,099
+537,649
+70% +$28.9M 0.16% 122
2018
Q3
$47.5M Buy
764,450
+44,019
+6% +$2.61M 0.1% 161
2018
Q2
$39.9M Buy
720,431
+2,560
+0.4% +$138K 0.1% 156
2018
Q1
$45.4M Sell
717,871
-69,251
-9% -$4.45M 0.11% 137
2017
Q4
$48.2M Sell
787,122
-34,326
-4% -$2.15M 0.11% 137
2017
Q3
$52.4M Buy
821,448
+84,180
+11% +$4.92M 0.13% 136
2017
Q2
$41.1M Buy
737,268
+65,742
+10% +$3.58M 0.1% 140
2017
Q1
$36.5M Buy
671,526
+428,348
+176% +$23.5M 0.1% 142
2016
Q4
$14.2M Sell
243,178
-8,444
-3% -$462K 0.04% 242
2016
Q3
$13.6M Sell
251,622
-4,640
-2% -$298K 0.04% 241
2016
Q2
$18.8M Buy
256,262
+37,667
+17% +$2.66M 0.05% 194
2016
Q1
$14M Sell
218,595
-58,983
-21% -$3.72M 0.04% 209
2015
Q4
$19.1M Sell
277,578
-5,333
-2% -$352K 0.06% 188
2015
Q3
$16.7M Sell
282,911
-6,852
-2% -$435K 0.06% 180
2015
Q2
$19.3M Sell
289,763
-19,813
-6% -$1.31M 0.07% 179
2015
Q1
$20M Sell
309,576
-87,628
-22% -$5.49M 0.07% 177
2014
Q4
$23.4M Sell
397,204
-5,765
-1% -$325K 0.09% 169
2014
Q3
$20.6M Sell
402,969
-39,524
-9% -$1.97M 0.08% 171
2014
Q2
$21.5M Buy
442,493
+3,608
+0.8% +$178K 0.09% 169
2014
Q1
$22.8M Buy
438,885
+462
+0.1% +$24.6K 0.11% 152
2013
Q4
$23.3M Buy
438,423
+310,557
+243% +$15.8M 0.12% 147
2013
Q3
$5.92M Sell
127,866
-33,695
-21% -$1.48M 0.03% 268
2013
Q2
$7.22M Buy
+161,561
New +$7.01M 0.04% 238

Other funds holding BMY

Nordea Investment Management's BMY Position: Q1 2026 in Review

Nordea Investment Management increased its Bristol-Myers Squibb (BMY) stake by 915% in Q1 2026, buying an estimated $107M and bringing the position to 2,033,068 shares worth $122M. The position accounts for 0.11% of the portfolio, ranked #175.

Nordea Investment Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.14B in Q4 2021. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Nordea Investment Management held 2,033,068 shares of Bristol-Myers Squibb worth $122M as of Q1 2026.
  • Nordea Investment Management bought 1,832,750 Bristol-Myers Squibb shares in Q1 2026, an estimated $107M.
  • Bristol-Myers Squibb made up 0.11% of Nordea Investment Management's portfolio in Q1 2026, its #175 holding.
  • Nordea Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Nordea Investment Management's Bristol-Myers Squibb position peaked at $1.14B in Q4 2021.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.